疏血通联合吡拉西坦氯化钠对急性脑梗死患者认知功能的改善作用

冯彦梅

（邳州市中医院，江苏 徐州，221300）

浏览次数：125次 下载次数：335次

摘要：

目的 探讨疏血通联合吡拉西坦氯化钠对急性脑梗死患者认知功能的改善作用。方法 选择我院收治的急性脑梗死患者60例为研究对象，将其分为对照组和观察组，每组30 例。对照组患者给予吡拉西坦氯化钠治疗，观察组给予疏血通联合吡拉西坦氯化钠治疗。比较两组患者的临床效果及治疗前、后的认知功能。结果 观察组患者的治疗总有效率为86.67%，明显 高于对照组患者的56.67%（P<0.05）；治疗后，两组患者的MMSE、BI 及NDS 评分均优于治疗前，且观察组明显优于对照 组（P<0.05）。结论 疏血通联合吡拉西坦氯化钠应用于急性脑梗死治疗可显著提高临床效果，有助于改善梗死区域的循环障 碍和代谢障碍，促进细胞修复和再生，在提高患者认知功能方面具有确切作用。

关键词：疏血通；急性脑梗死；吡拉西坦氯化钠

中图分类号：R743.3 文献标志码：A文章编号：2096-1413(2017)34-0037-02

Effect of Shuxuetong combined with piracetam sodium chloride on cognitive function in patients with acute cerebral infarction
FENG Yan-mei
(Traditional Chinese Medicine Hospital of Pizhou, Xuzhou 221300, China)

ABSTRACT: Objective To investigate the effect of Shuxuetong combined with piracetam sodium chloride on cognitive function in patients with acute cerebral infarction. Methods Sixty cases of patients with acute cerebral infarction were selected and divided into control group and observation group, with 30 cases in each group. The control group was treated with piracetam sodium chloride, the observation group was treated with Shuxuetong combined with piracetam sodium chloride. The clinical effects and cognitive function before and after treatment of the two groups were compared. Results The total effective rate of the observation group was 86.67%, which was higher than 56.67% of the control group (P<0.05). After treatment, the MMSE, BI and NDS scores of the two groups were better than those before treatment, and those of the observation group were better than the control group (P<0.05). Conclusion Shuxuetong combined with piracetam sodium chloride in the treatment of acute cerebral infarction can significantly improve the therapeutic effect, help to improve the existing regional circulation infarction and metabolic disorders, and promote cell regeneration and repair, it has a definite role in improving the cognitive function of the patients.
KEYWORDS: Shuxuetong; acute cerebral infarction; piracetam sodium chloride

参考文献：
[1] 柏峻霞,王义兰,李梁蜜,等.奥拉西坦与吡拉西坦治疗动脉粥样硬 化性脑梗死急性期认知功能障碍对照研究[J].中国药业,2015,24(24):29-31.
[2] 闫卫静.血栓通注射液联合吡拉西坦氯化钠注射液改善急性脑梗 死患者神经功能缺损疗效分析[J].临床合理用药杂志,2014,7(22):44-45.
[3] 芦玉莲.血栓通联合吡拉西坦氯化钠注射液治疗急性脑梗死疗效 分析[J].中国实用神经疾病杂志,2013,16(14):83-84.
[4] 张东方,张锦,李冉.血栓通注射液联合吡拉西坦氯化钠注射液治 疗老年急性脑梗死患者的疗效[J].中国老年学,2015,35(17):4867-4868.
[5] AMARENCO P,ALBERS G W,DENISON H,et al.Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind,controlled trial[J].Lancet Neurol,2017,16(4):301-310.
[6] 刘婷.疏血通注射液联合吡拉西坦注射液治疗急性脑梗死疗效观 察[J].健康必读(旬刊),2012,11(9):405.